EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Circulating Tumor Cells in Multiple Myeloma: From Peripheral Clues to Central Insights

Benjamin Podvin iD, Bruno Paiva, Irene M Ghobrial, Salomon Manier

American Journal of Hematology · 2026

DOI: 10.1002/ajh.70326 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Hematology, 2026. Verfasst von Benjamin Podvin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Hematology, Lille University Hospital, Lille, France. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Multiple Myeloma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating tumor cells (CTCs) have emerged as a key component of liquid biopsy in multiple myeloma (MM), reflecting the ability of malignant plasma cells to escape the bone marrow (BM) niche, disseminate systemically, and contribute to disease progression. Their detection in peripheral blood is now feasible across the disease spectrum, from MGUS and smoldering myeloma to solitary plasmacytoma, symptomatic MM, and plasma cell leukemia, providing a dynamic window into tumor biology. Technological advances, including high‐sensitivity flow cytometry and next‐generation single‐cell sequencing, have enabled accurate enumeration and molecular interrogation of CTC. Beyond their biological significance, CTC quantification has consistently demonstrated independent prognostic value at diagnosis, with even low levels predicting inferior survival outcomes. Recent proof‐of‐concept studies, such as MinimuMM‐seq and SWIFT‐seq, established that genomic and transcriptomic profiling of CTC can recapitulate canonical myeloma lesions, reveal clonal heterogeneity and track evolutionary dynamics under therapy. Importantly, persistent or reemergent CTC after are occasionally observed and, when present, may signal relapse, particularly, in patients with BM‐MRD positivity, highlighting their potential as complementary biomarkers alongside established BM MRD assessment. Although methodological challenges remain—particularly, standardization, sensitivity, and integration into clinical workflows—CTC analysis holds the promise of transforming from a surrogate biomarker to a clinically actionable tool, advancing precision medicine in MM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingMultiple MyelomaHumansBiomarkers, TumorPrognosisNeoplasm, ResidualBone MarrowFlow Cytometry

Stichwörter der Autor:innen

circulating tumoral cellsflow cytometrygenomicsmultiple myeloma

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Laboratory of Hematology, Lille University Hospital, Lille, France.
  • PERSTIM Lab, INSERM UMR-S1277, Lille University, Lille, France.
  • Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBER-ONC CB16/12/00369, Pamplona, Spain.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Department of Clinical Hematology, Lille University Hospital, Lille, France.

ORCID-Profile: Benjamin Podvin

Zitieren

APA

Podvin, B., Paiva, B., Ghobrial, I. M., & Manier, S. (2026). Circulating Tumor Cells in Multiple Myeloma: From Peripheral Clues to Central Insights. American Journal of Hematology. https://doi.org/10.1002/ajh.70326

Vancouver

Podvin B, Paiva B, Ghobrial IM, Manier S. Circulating Tumor Cells in Multiple Myeloma: From Peripheral Clues to Central Insights. American Journal of Hematology. 2026. doi:10.1002/ajh.70326

BibTeX
@article{Podvin2026,
  author = {Podvin, Benjamin and Paiva, Bruno and Ghobrial, Irene M and Manier, Salomon},
  title = {Circulating Tumor Cells in Multiple Myeloma: From Peripheral Clues to Central Insights},
  journal = {American Journal of Hematology},
  year = {2026},
  doi = {10.1002/ajh.70326}
}
Kostenlos starten →